Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button


Home > Press > Roche Leads Biotechnology Industry With An Unprecedented Growth Of Nearly 100%, While Geron, Nanosphere And Ultra Biotech Jump Into The Top 10 Patent

According to The Patent Board's Biotechnology Patent Scorecard published in The Wall Street Journal, Roche's top billing is due to their ownership in Genentech.

Roche Holding Ltd remains the leader for the Biotechnology Scorecard, with an unprecedented Science Strength (SS) that grew by almost 100% this past quarter. Their lead is primarily due to majority owned subsidiary and biotech, Genentech, who account for approximately 80% of the patents represented. Geron Corp, known for stem cell research has soared into the top 10 moving up 7 spots to sit in 5th position with an increase in SS™ of 77%. There are two other newcomers to the top 10, one of which is Nanosphere Inc, who is bringing the combination of nanotechnology and molecular diagnostics into the marketplace. The other is little known Ultra Biotech Ltd which utilizes electromagnetic energy for culturing biotechnology compositions.

Eight of the top 10 companies have above average Research Intensity (RI), which measures the degree of scientific referencing for their most recent patenting compared to others in the industry. The largest increases in Research Intensity™ this quarter came from 1st and 2nd ranked, Roche (52%) and Invitrogen (23%), while newcomers Geron and Nanosphere have the highest scores among the top 10 of 3.43 and 3.29 respectively. They are both referencing well known publications such as Proceedings of the National Academy of Science and The Journal of Biological Chemistry; however Nanosphere is also highly referencing the interdisciplinary journal, Langmuir, further showing its differentiation in the marketplace. Another company who is highly referencing Langmuir is Affymetrix, ranked 18th (not charted) who pioneered the use of semiconductors and combinatorial chemistry for biotechnology use. Despite dropping a spot each this quarter, both Isis Pharmaceuticals Inc and Biogen Idec Inc have RI scores twice the industry average.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Pixelligent Launches New PixClear® Light Extraction Materials for OLED Lighting August 4th, 2015

The annual meeting on High Power Diode Lasers & Systems will be held as part of the Enlighten Conference, October 14th & 15th August 4th, 2015

Atomic view of microtubules: Berkeley Lab researchers achieve record 3.5 angstroms resolution and visualize action of a major microtubule-regulating protein August 4th, 2015

World's quietest gas lets physicists hear faint quantum effects August 4th, 2015


Artificial blood vessels become resistant to thrombosis August 4th, 2015

Engineering a better 'Do: Purdue researchers are learning how August 4th, 2015

Proving nanoparticles in sunscreen products August 4th, 2015

Global Carbon Nanotubes Industry 2015: Acute Market Reports August 4th, 2015

Patents/IP/Tech Transfer/Licensing

Quantum networks: Back and forth are not equal distances! July 28th, 2015

Reshaping the solar spectrum to turn light to electricity: UC Riverside researchers find a way to use the infrared region of the sun's spectrum to make solar cells more efficient July 27th, 2015

Smarter window materials can control light and energy July 22nd, 2015

Magnetic nanoparticles could be key to effective immunotherapy: New method moves promising strategy closer to clinical use July 15th, 2015

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
University Technology Transfer & Patents
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project